World > Review

The WHO is reopening its study of hydroxychloroquine for coronavirus treatment - but whether the drug works is still in question

The World Health Organization is restarting its hydroxychloroquine study for the treatment of COVID-19, the disease caused by the coronavirus after it paused the trial last week to conduct a safety review.
The WHO says it has not seen "any differences in mortality" among coronavirus patients who use the drug when compared to those who don't.
But whether hydroxychloroquine "works or doesn't work" to help treat or prevent coronavirus cases is still unknown.
Visit Business Insider's homepage for more stories .
The World Health Organization's hydroxychloroquine trial for coronavirus treatment...
Read more ...

WHO resumes hydroxychloroquine study for Covid-19, after reviewing safety concerns

2 monthes ago | By STAT

The World Health Organization is resuming a clinical trial exploring whether the malaria drug hydroxychloroquine can effectively treat Covid-19, after pausing enrollment in the study to review safety concerns about the drug.
The hydroxychloroquine investigation is just one arm of the agency's Solidarity Trial , which is testing different therapies to determine which are beneficial in the disease caused by the novel coronavirus. The WHO last week temporarily suspended the hydroxychloroquine arm after a separate study published in the Lancet raised warnings about the drug's safety.
Read more ...